Cortisol excess in chronic kidney disease - A review of changes and impact on mortality.

Sagmeister, Michael S; Harper, Lorraine; Hardy, Rowan S

Sagmeister, Michael S; Harper, Lorraine; Hardy, Rowan S.

Affiliation

Sagmeister MS; Institute for Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Harper L; Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Hardy RS; Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Front Endocrinol (Lausanne) ; 13: 1075809, 2022.

Article in En | MEDLINE | ID: mdl-36733794

Subject(s)

Hydrocortisone; Renal Insufficiency, Chronic; Adult; Humans; Hydrocortisone/metabolism; Glucocorticoids/metabolism; Hypothalamo-Hypophyseal System/metabolism; Pituitary-Adrenal System/metabolism

Key words

11beta-HSD; adrenal function; chronic disease; circadian rhythm; human; renal replacement therapy; steroid metabolism; subclinical hypercortisolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydrocortisone / Renal Insufficiency, Chronic Type of study: Guideline / Observational_studies Limits: Adult / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google